TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12/22/25 11:43 | 12/18/25 | KYTX | Kyverna Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Seidenberg Beth C | CA | D | P | 1,000 | 7.50 | 0 | 133 | 3 | 4,674 | I | |||||||||||||||
10/30/24 16:06 | 10/28/24 | VERA | Vera Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Seidenberg Beth C | CA | D | S | -720 | 48.03 | 0 | -15 | -10 | 136 | D | |||||||||||||||
9/20/24 16:45 | 9/18/24 | VERA | Vera Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Seidenberg Beth C | CA | D | S.m | -696 | 42.26 | 0 | -16 | -10 | 151 | M | |||||||||||||||
7/20/23 16:20 | 7/18/23 | SGMT | Sagimet Biosciences Inc. | DE | Health | Drug | Pharmaceutical Preparations | Seidenberg Beth C | CA | D | P.d | 750 | 16.00 | 0 | 47 | 2 | 2,031 | M | |||||||||||||||
5/11/23 21:13 | 5/9/23 | SLRN | Acelyrin, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Seidenberg Beth C | CA | DT | P.d | 23,580 | 18.00 | 0 | 1,310 | 15 | 9,851 | M |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |